北京大学学报(医学版) ›› 2021, Vol. 53 ›› Issue (5): 857-863. doi: 10.19723/j.issn.1671-167X.2021.05.008
JIANG Yan-fang,WANG Jian,Yong-WANG Jian,LIU Jia,PEI Yin,LIU Xiao-peng,AO Ying-fang,MA Yong()
摘要:
目的: 分析前交叉韧带翻修重建术后中长期临床疗效及预后影响因素。方法: 收集2001年1月至2015年12月间在北京大学第三医院运动医学科行膝关节前交叉韧带(anterior cruciate ligament,ACL)重建术首次翻修手术的235例患者,采集患者人口学信息、ACL首次翻修重建信息(移植物断裂时间、失效原因、翻修重建时间、手术技术、合并损伤及处理方式)和初次ACL重建手术时的信息(初次断裂时间、受伤原因、受伤机制、初次重建时间、手术技术、合并损伤及处理方式)。同时对患者进行术后2年以上的随访,随访内容包括疼痛视觉模拟评分(visual analogue scale,VAS)、Tegner活动水平评分、Lysholm评分、国际膝关节文献委员会(International Knee Documentation Committee,IKDC)膝关节主观评分、翻修术后同侧膝关节和对侧膝关节损伤和手术情况。通过多因素分析确定临床疗效的独立影响因素。结果: 按排除标准实际随访纳入166例(70.63%),平均随访时间(4.44±2.40)年(2.03~14.63年)。患者末次随访时Lysholm评分、Tegner活动水平评分、IKDC主观评分均较术前明显提高,分别从70.51±21.25、3.39±1.77、63.78±15.04提高至术后88.64±14.36、4.67±1.739和 80.23±13.31(P<0.05)。3例患者(1.81%)翻修术后出现感染,39例(23.49%)患者在随访期内同侧和对侧膝关节再次接受手术(41例次)。与运动损伤导致的移植物失效相比,因生活意外或初次重建手术技术原因导致翻修的患者术后评分显著偏低(P<0.05):Lysholm评分分别低9.90(95%CI:1.49~18.31)、8.53(95%CI:1.31~15.75), IKDC分别低10.35(95%CI:0.17~20.54)和9.39(95%CI:1.03~17.74),Tegner活动水平评分分别低1.41(95%CI:0.10~2.72)和1.28(95%CI:0.14~2.43)。经胫骨骨道钻取股骨骨道的患者术后Lysholm评分较经前内入路患者低11.18(95%CI:4.73~17.63, P=0.001)。术中同期进行内侧半月板缝合的患者术后IKDC评分较无半月板合并损伤患者高11.06(95%CI:1.21~20.92, P=0.029)。其他预后因素差异无统计学意义。结论: ACL翻修术可提高患者膝关节稳定性,明显改善膝关节功能。与生活意外或初次重建手术技术原因导致的翻修相比,运动损伤导致移植物失效的患者术后疗效恢复更好。内侧半月板缝合和经前内入路钻取股骨骨道对ACL翻修术后的临床功能在统计学上体现出保护作用。
中图分类号:
[1] |
Lind M, Menhert F, Pedersen AB. Incidence and outcome after revision anterior cruciate ligament reconstruction: Results from the Danish registry for knee ligament reconstructions [J]. Am J Sports Med, 2012, 40(7):1551-1557.
doi: 10.1177/0363546512446000 |
[2] |
Hettrich CM, Dunn WR, Reinke EK, et al. The rate of subsequent surgery and predictors after anterior cruciate ligament reconstruction: Two- and 6-year follow-up results from a multicenter cohort [J]. Am J Sports Med, 2013, 41(7):1534-1540.
doi: 10.1177/0363546513490277 pmid: 23722056 |
[3] |
Wasserstein D, Khoshbin A, Dwyer T, et al. Risk factors for recurrent anterior cruciate ligament reconstruction: A population study in Ontario, Canada, with 5-year follow-up [J]. Am J Sports Med, 2013, 41(9):2099-2107.
doi: 10.1177/0363546513493580 pmid: 23857886 |
[4] |
Maletis GB, Inacio MC, Funahashi TT. Analysis of 16 192 ante-rior cruciate ligament reconstructions from a community-based registry [J]. Am J Sports Med, 2013, 41(9):2090-2098.
doi: 10.1177/0363546513493589 |
[5] |
Leroux T, Wasserstein D, Dwyer T, et al. The epidemiology of revision anterior cruciate ligament reconstruction in Ontario, Canada [J]. Am J Sports Med, 2014, 42(11):2666-2672.
doi: 10.1177/0363546514548165 |
[6] |
Group M. Predictors of clinical outcome following revision anterior cruciate ligament reconstruction [J]. J Orthop Res, 2020, 38(6):1191-1203.
doi: 10.1002/jor.v38.6 |
[7] |
Yan X, Yang XG, Feng JT, et al. Does revision anterior cruciate ligament (ACL) reconstruction provide similar clinical outcomes to primary ACL reconstruction? A systematic review and meta-analysis [J]. Orthop Surg, 2020, 12(6):1534-1546.
doi: 10.1111/os.v12.6 |
[8] | Ma Y, Ao YF, Yu JK, et al. Failed anterior cruciate ligament reconstruction: Analysis of factors leading to instability after primary surgery [J]. Chin Med J (Engl), 2013, 126(2):280-285. |
[9] |
Grossman MG, ElAttrache NS, Shields CL, et al. Revision ante-rior cruciate ligament reconstruction: Three- to nine-year follow-up [J]. Arthroscopy, 2005, 21(4):418-423.
pmid: 15800521 |
[10] |
O’Neill DB. Revision arthroscopically assisted anterior cruciate ligament reconstruction with previously unharvested ipsilateral autografts [J]. Am J Sports Med, 2004, 32(8):1833-1841.
doi: 10.1177/0363546504264585 |
[11] |
Garofalo R, Djahangiri A, Siegrist O. Revision anterior cruciate ligament reconstruction with quadriceps tendon-patellar bone autograft [J]. Arthroscopy, 2006, 22(2):205-214.
doi: 10.1016/j.arthro.2005.08.045 |
[12] | 任忠明, 谢国庆, 金文孝, 等. 关节镜下前交叉韧带重建术后失败行翻修术的近中期临床疗效 [J]. 武警医学, 2020, 31(8):654-656. |
[13] |
Granan LP, Inacio MC, Maletis GB, et al. Intraoperative findings and procedures in culturally and geographically different patient and surgeon populations: An anterior cruciate ligament reconstruction registry comparison between Norway and the USA [J]. Acta Orthop, 2012, 83(6):577-582.
doi: 10.3109/17453674.2012.741451 |
[14] |
Griffith TB, Allen BJ, Levy BA, et al. Outcomes of repeat revision anterior cruciate ligament reconstruction [J]. Am J Sports Med, 2013, 41(6):1296-1301.
doi: 10.1177/0363546513482568 pmid: 23605223 |
[15] |
Noyes FR, Barber-Westin SD. Anterior cruciate ligament revision reconstruction: Results using a quadriceps tendon-patellar bone autograft [J]. Am J Sports Med, 2006, 34(4):553-564.
doi: 10.1177/0363546505281812 |
[16] |
Ohly NE, Murray IR, Keating JF. Revision anterior cruciate ligament reconstruction: Timing of surgery and the incidence of meniscal tears and degenerative change [J]. J Bone Joint Surg Br, 2007, 89(8):1051-1054.
pmid: 17785744 |
[17] |
Trojani C, Sbihi A, Djian P, et al. Causes for failure of ACL reconstruction and influence of meniscectomies after revision [J]. Knee Surg Sports Traumatol Arthrosc, 2011, 19(2):196-201.
doi: 10.1007/s00167-010-1201-6 |
[18] |
Widener DB, Wilson DJ, Galvin JW, et al. The prevalence of meniscal tears in young athletes undergoing revision anterior cruciate ligament reconstruction [J]. Arthroscopy, 2015, 31(4):680-683.
doi: 10.1016/j.arthro.2014.10.006 |
[19] |
Group M. Meniscal and articular cartilage predictors of clinical outcome after revision anterior cruciate ligament reconstruction [J]. Am J Sports Med, 2016, 44(7):1671-1679.
doi: 10.1177/0363546516644218 |
[20] |
Wegrzyn J, Chouteau J, Philippot R, et al. Repeat revision of anterior cruciate ligament reconstruction: A retrospective review of management and outcome of 10 patients with an average 3-year follow-up [J]. Am J Sports Med, 2009, 37(4):776-785.
doi: 10.1177/0363546508330141 pmid: 19336620 |
[21] |
Wright RW, Gill CS, Chen L, et al. Outcome of revision anterior cruciate ligament reconstruction: A systematic review [J]. J Bone Joint Surg Am, 2012, 94(6):531-536.
doi: 10.2106/JBJS.K.00733 pmid: 22438002 |
[22] |
Yoon KH, Lee HW, Park JY, et al. Clinical outcomes and the failure rate of revision anterior cruciate ligament reconstruction were comparable between patients younger than 40 years and patients older than 40 years: A minimum 2-year follow-up study [J]. Arthroscopy, 2020, 36(9):2513-2522.
doi: 10.1016/j.arthro.2020.06.012 |
[23] | 运行, 魏钰, 李众利, 等. 前交叉韧带翻修术中期疗效研究 [J]. 中国修复重建外科杂志, 2021, 35(1):58-63. |
[24] |
Group M, Wright RW, Huston LJ, et al. Predictors of patient-reported outcomes at 2 years after revision anterior cruciate ligament reconstruction [J]. Am J Sports Med, 2019, 47(10):2394-2401.
doi: 10.1177/0363546519862279 pmid: 31318611 |
[1] | 任爽, 时会娟, 梁子轩, 张思, 胡晓青, 黄红拾, 敖英芳. 前交叉韧带重建术后侧切动作的生物力学特征[J]. 北京大学学报(医学版), 2024, 56(5): 868-873. |
[2] | 欧俊永,倪坤明,马潞林,王国良,颜野,杨斌,李庚午,宋昊东,陆敏,叶剑飞,张树栋. 肌层浸润性膀胱癌合并中高危前列腺癌患者的预后因素[J]. 北京大学学报(医学版), 2024, 56(4): 582-588. |
[3] | 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630. |
[4] | 虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报(医学版), 2024, 56(4): 661-666. |
[5] | 周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报(医学版), 2024, 56(4): 673-679. |
[6] | 方杨毅,李强,黄志高,陆敏,洪锴,张树栋. 睾丸鞘膜高分化乳头状间皮肿瘤1例[J]. 北京大学学报(医学版), 2024, 56(4): 741-744. |
[7] | 曾媛媛,谢云,陈道南,王瑞兰. 脓毒症患者发生正常甲状腺性病态综合征的相关因素[J]. 北京大学学报(医学版), 2024, 56(3): 526-532. |
[8] | 王江静,魏顺依,敖英芳,杨渝平. 前交叉韧带重建术后三种不同药物镇痛早期疗效的对比[J]. 北京大学学报(医学版), 2024, 56(2): 293-298. |
[9] | 苏俊琪,王晓颖,孙志强. 舌鳞状细胞癌根治性切除术后患者预后预测列线图的构建与验证[J]. 北京大学学报(医学版), 2024, 56(1): 120-130. |
[10] | 李建斌,吕梦娜,池强,彭一琳,刘鹏程,吴锐. 干燥综合征患者发生重症新型冠状病毒肺炎的早期预测[J]. 北京大学学报(医学版), 2023, 55(6): 1007-1012. |
[11] | 刘欢锐,彭祥,李森林,苟欣. 基于HER-2相关基因构建风险模型用于膀胱癌生存预后评估[J]. 北京大学学报(医学版), 2023, 55(5): 793-801. |
[12] | 薛子璇,唐世英,邱敏,刘承,田晓军,陆敏,董靖晗,马潞林,张树栋. 青年肾肿瘤伴瘤栓的临床病理特征及预后分析[J]. 北京大学学报(医学版), 2023, 55(5): 802-811. |
[13] | 卢汉,张建运,杨榕,徐乐,李庆祥,郭玉兴,郭传瑸. 下颌牙龈鳞状细胞癌患者预后的影响因素[J]. 北京大学学报(医学版), 2023, 55(4): 702-707. |
[14] | 时云飞,王豪杰,刘卫平,米岚,龙孟平,刘雁飞,赖玉梅,周立新,刁新婷,李向红. 血管免疫母细胞性T细胞淋巴瘤临床与分子病理学特征分析[J]. 北京大学学报(医学版), 2023, 55(3): 521-529. |
[15] | 朱晓娟,张虹,张爽,李东,李鑫,徐玲,李挺. 人表皮生长因子受体2低表达乳腺癌的临床病理学特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 243-253. |
|